Swiss National Bank Cure Vac N.V. Transaction History
Swiss National Bank
- $137 Billion
- Q1 2025
A detailed history of Swiss National Bank transactions in Cure Vac N.V. stock. As of the latest transaction made, Swiss National Bank holds 198,547 shares of CVAC stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
198,547
Previous 198,547
-0.0%
Holding current value
$1.06 Million
Previous $677,000
18.91%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CVAC
# of Institutions
102Shares Held
14.2MCall Options Held
270KPut Options Held
114K-
Black Rock Inc. New York, NY2.25MShares$12 Million0.0% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ1.97MShares$10.5 Million0.58% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$8.38 Million10.6% of portfolio
-
Qube Research & Technologies LTD London, X01.18MShares$6.31 Million0.01% of portfolio
-
Water Island Capital LLC New York, NY957KShares$5.11 Million1.03% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $1B
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...